James H Browning

Insider

First SEC filing: Oct. 27, 2009 · Latest: Oct. 27, 2009

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Initial holdings The stakes this person held when they first started reporting.

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 33 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

33 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 15, 2025	HRI	A	967	—	—	14,894 Direct	+6.94%	Acquired	(price as of 2026-08-21)
April 23, 2025	TCBIO	M	1,330	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
April 23, 2025	TCBIO	M	1,330	—	—	21,304 Direct	+6.66%	Acquired	(price as of 2026-08-21)
May 16, 2024	HRI	A	834	—	—	13,927 Direct	+6.37%	Acquired	(price as of 2026-08-21)
April 23, 2024	TCBIO	A	1,330	—	—	1,330 Direct	—	Acquired	(price as of 2026-08-21)
April 18, 2024	TCBIO	M	1,631	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
April 18, 2024	TCBIO	M	1,631	—	—	19,974 Direct	+8.89%	Acquired	(price as of 2026-08-21)
May 11, 2023	HRI	A	1,301	—	—	13,093 Direct	+11.03%	Acquired	(price as of 2026-08-21)
April 19, 2023	TCBIO	M	1,377	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
April 19, 2023	TCBIO	M	1,377	—	—	18,343 Direct	+8.12%	Acquired	(price as of 2026-08-21)
April 18, 2023	TCBIO	A	1,631	—	—	1,631 Direct	—	Acquired	(price as of 2026-08-21)
May 12, 2022	HRI	A	1,101	—	—	11,792 Direct	+10.30%	Acquired	(price as of 2026-08-21)
April 19, 2022	TCBIO	A	1,377	—	—	18,343 Direct	+8.12%	Acquired	(price as of 2026-08-21)
Nov. 4, 2021	HRI	P	4	$184.80	$739	7,065 Direct	+0.06%	Acquired	-12.1% (price as of 2026-08-21)
Oct. 25, 2021	TCBIO	P	1,000	$59.56	$59,560	16,966 Direct	+6.26%	Acquired	-65.3% (price as of 2026-08-21)
May 13, 2021	HRI	A	1,034	—	—	10,691 Direct	+10.71%	Acquired	(price as of 2026-08-21)
April 20, 2021	TCBIO	A	1,015	—	—	15,966 Direct	+6.79%	Acquired	(price as of 2026-08-21)
June 29, 2020	TCBIO	A	2,242	—	—	14,951 Direct	+17.64%	Acquired	(price as of 2026-08-21)
May 14, 2020	HRI	A	4,819	—	—	9,657 Direct	+99.61%	Acquired	(price as of 2026-08-21)
Jan. 29, 2020	TCBIO	M	3,000	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
Jan. 29, 2020	TCBIO	F	1,021	$54.54	$55,685	12,709 Direct	-7.44%	Disposed	-62.1% (price as of 2026-08-21)
Jan. 29, 2020	TCBIO	M	3,000	$18.52	$55,560	13,730 Direct	+27.96%	Acquired	11.6% (price as of 2026-08-21)
May 16, 2019	HRI	A	2,578	—	—	4,838 Direct	+114.07%	Acquired	(price as of 2026-08-21)
April 16, 2019	TCBIO	A	1,107	—	—	10,730 Direct	+11.50%	Acquired	(price as of 2026-08-21)
May 17, 2018	HRI	A	1,704	—	—	7,061 Direct	+31.81%	Acquired	(price as of 2026-08-21)
April 17, 2018	TCBIO	A	611	—	—	9,623 Direct	+6.78%	Acquired	(price as of 2026-08-21)
Feb. 26, 2018	HRI	A	1,000	—	—	5,357 Direct	+22.95%	Acquired	(price as of 2026-08-21)
May 18, 2017	HRI	A	2,857	—	—	4,357 Direct	+190.47%	Acquired	(price as of 2026-08-21)
April 18, 2017	TCBIO	A	698	—	—	9,012 Direct	+8.40%	Acquired	(price as of 2026-08-21)
Aug. 18, 2016	HRI	A	2,260	—	—	2,260 Direct	—	Acquired	(price as of 2026-08-21)
Aug. 12, 2016	HRI	P	1,500	$32.94	$49,410	1,500 Direct	—	Acquired	393.4% (price as of 2026-08-21)
May 17, 2016	TCBIO	A	1,023	—	—	10,814 Direct	+10.45%	Acquired	(price as of 2026-08-21)
Feb. 25, 2016	TCBIO	P	1,500	$30.50	$45,750	9,791 Direct	+18.09%	Acquired	-32.3% (price as of 2026-08-21)
May 19, 2015	TCBIO	A	816	—	—	8,291 Direct	+10.92%	Acquired	(price as of 2026-08-21)
May 18, 2010	TCBIO	A	3,000	—	—	3,000 Direct	—	Acquired	(price as of 2026-08-21)
May 18, 2010	TCBIO	A	1,000	—	—	1,000 Direct	—	Acquired	(price as of 2026-08-21)
Oct. 20, 2009	TCBIO	A	3,000	—	—	5,000 Direct	+150.00%	Acquired	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
May 15, 2025	HRI	Phantom Stock	Common Stock (967)	—	—	967	Acquired
April 23, 2025	TCBIO	2024 Restricted Stock Units	Common Stock (1,330)	$0.00	—	1,330	Disposed
May 16, 2024	HRI	Phantom Stock	Common Stock (834)	—	—	834	Acquired
April 23, 2024	TCBIO	2024 Restricted Stock Units	Common Stock (1,330)	$0.00	—	1,330	Acquired
April 18, 2024	TCBIO	Restricted Stock Units	Common Stock (1,631)	$0.00	—	1,631	Disposed
May 11, 2023	HRI	Phantom Stock	Common Stock (1,301)	—	—	1,301	Acquired
April 19, 2023	TCBIO	Restricted Stock Units	Common Stock (1,377)	$0.00	—	1,377	Disposed
April 18, 2023	TCBIO	Restricted Stock Units	Common Stock (1,631)	$0.00	—	1,631	Acquired
May 12, 2022	HRI	Phantom Stock	Common Stock (1,101)	—	—	1,101	Acquired
May 13, 2021	HRI	Phantom Stock	Common Stock (1,034)	—	—	1,034	Acquired
May 14, 2020	HRI	Phantom Stock	Common Stock (4,819)	—	—	4,819	Acquired
Jan. 29, 2020	TCBIO	Stock Appreciation Rights	Common Stock (3,000)	$18.52	May 18, 2020	3,000	Disposed
May 16, 2019	HRI	Phantom Stock	Common Stock (2,578)	—	—	2,578	Acquired
Aug. 18, 2016	HRI	Phantom Stock	Common Stock (2,260)	—	—	2,260	Acquired
May 18, 2010	TCBIO	Stock Appreciation Rights [F4]	Common Stock (3,000)	$18.52	May 18, 2020	3,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Oct. 27, 2009	TCBIO	Common Stock	2,000	Direct